首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5978篇
  免费   313篇
  国内免费   32篇
耳鼻咽喉   78篇
儿科学   148篇
妇产科学   127篇
基础医学   854篇
口腔科学   378篇
临床医学   523篇
内科学   1375篇
皮肤病学   131篇
神经病学   611篇
特种医学   74篇
外科学   561篇
综合类   25篇
一般理论   2篇
预防医学   552篇
眼科学   89篇
药学   419篇
中国医学   41篇
肿瘤学   335篇
  2024年   5篇
  2023年   64篇
  2022年   157篇
  2021年   287篇
  2020年   161篇
  2019年   263篇
  2018年   293篇
  2017年   152篇
  2016年   169篇
  2015年   212篇
  2014年   297篇
  2013年   323篇
  2012年   570篇
  2011年   613篇
  2010年   303篇
  2009年   271篇
  2008年   396篇
  2007年   348篇
  2006年   326篇
  2005年   247篇
  2004年   227篇
  2003年   208篇
  2002年   181篇
  2001年   33篇
  2000年   13篇
  1999年   26篇
  1998年   17篇
  1997年   15篇
  1996年   17篇
  1995年   19篇
  1994年   5篇
  1993年   11篇
  1992年   15篇
  1991年   10篇
  1990年   8篇
  1989年   5篇
  1988年   3篇
  1987年   5篇
  1984年   3篇
  1983年   3篇
  1982年   2篇
  1979年   2篇
  1978年   5篇
  1975年   2篇
  1974年   4篇
  1972年   5篇
  1971年   4篇
  1970年   6篇
  1967年   2篇
  1966年   3篇
排序方式: 共有6323条查询结果,搜索用时 12 毫秒
31.
Supplementation in malnourished pregnant women should not displace natural healthy foods. Objective: To estimate the differential effects of three nutritional supplements on macro- and micronutrient intake of pregnant women beneficiaries of the conditional cash transfer program Prospera (CCT-POP). Methods: Prospective cluster randomized trial. Communities were randomly assigned to receive a fortified beverage (Beverage), micronutrient tablets (Tablets), or micronutrient powder (MNP). Pregnant women (at <25 weeks) were recruited. The food frequency questionnaire was applied at 25 and 37 weeks of pregnancy and at one and three months postpartum (mpp). Differential effects of the three supplements on the median change in nutrient intake from baseline to each follow-up stage were estimated. Results: Median change in protein intake from dietary and supplement sources were significantly lower for MNP and Tablets than for Beverages (baseline to 37 w: −7.80 ± 2.90 and −11.54 ± 3.00, respectively; baseline to 1 mpp: −7.34 ± 2.90 for MNP, p < 0.001). Compared to Beverages, median increases were higher for the MNP for vitamins C (31.2 ± 11.7, p < 0.01), E (1.67 ± 0.81, p < 0.05), and B12 (0.83 ± 0.27, p < 0.01) from baseline to 37 wk; from baseline to 1 mpp, there was a higher median increase in B12 (0.55 ± 0.25, p < 0.05) and folate (63.4 ± 24.3, p < 0.01); and from baseline to 3 mpp, a higher median increase in iron (2.38 ± 1.06, p < 0.05) and folate (94.4 ± 38.1, p < 0.05). Conclusions: Intake of micronutrients was higher for MNP and Tablets, likely due to food displacement among Beverage consumers. Although iron bioavailability and absorption inhibitors were not considered for the present analyses, the distribution of Tablets or MNP had several advantages in this context where micronutrient deficiency remains high among pregnant women, but macronutrient intake is generally adequate or even high.  相似文献   
32.
33.
34.
35.
36.
37.
This study aimed to evaluate the mechanism associated with cytotoxic activity displayed by the drug 5-fluorouracil incorporated in Cu-BTC MOF and its slow delivery from the Cu-BTC MOF. Structural characterization encompasses elemental analysis (CHNS), differential scanning calorimetry (DSC), thermogravimetric analysis (TG/DTG), Fournier transform infrared (FIT-IR) and X-ray diffraction (XRD) was performed to verify the process of association between the drug 5-FU and Cu-BTC MOF. Flow cytometry was done to indicate that apoptosis is the mechanism responsible for the cell death. The release profile of the drug 5-FU from Cu-BTC MOF for 48 hours was obeisant. Also, the anti-inflammatory activity was evaluated by the peritonitis testing and the production of nitric oxide and pro-inflammatory cytokines were measured. The chemical characterization of the material indicated the presence of drug associated with the coordination network in a proportion of 0.82 g 5-FU per 1.0 g of Cu-BTC MOF. The cytotoxic tests were carried out against four cell lines: NCI-H292, MCF-7, HT29 and HL60. The Cu-BTC MOF associated drug was extremely cytotoxic against the human breast cancer adenocarcinoma (MCF-7) cell line and against human acute promyelocytic leukemia cells (HL60), cancer cells were killed by apoptosis mechanisms. The drug demonstrated a slow release profile where 82% of the drug was released in 48 hours. The results indicated that the drug incorporated in Cu-BTC MOF decreased significantly the number of leukocytes in the peritoneal cavity of rodents as well as reduced levels of cytokines and nitric oxide production.  相似文献   
38.
BackgroundBioFoot® is an in-shoe system to measure plantar pressures at the interface between the shoe and the sole of the foot. Since reliability and good repeatability are necessary to ensure the consistency of measurements on which clinical judgements are based, the aim of the study was to assess the reliability and repeatability of the BioFoot® system and identify normal values for healthy subjects.Materials and methodsThirty subjects, 18 women and 12 men, were measured twice, with a 7–10 day interval between the sessions, wearing the same kind of shoes. In each session, three trials were recorded. The foot was divided into ten areas: heel, midfoot, whole forefoot, 1st–5th metatarsal heads, hallux, and lesser toes.ResultsThe intra-class correlation coefficients were between 0.76 and 0.96 for all four variables evaluated. The coefficient of variation between two sessions was around 7% (range: 4.6–9%). The mean contact time was 0.81 s, and walking cadence was 101.5 steps per minute. The pressure measurements showed the greatest peak and mean pressures under the second metatarsal head, and the second peak and mean pressures under the third metatarsal head.ConclusionThe plantar pressure measurements showed good to excellent consistency, and it was concluded that the BioFoot® in-shoe system has good reliability and is repeatable. The highest values were found beneath the forefoot, which is consistent with the literature.  相似文献   
39.
The aim of the present study was to determine the effect of low-level laser therapy (LLLT) on the expression of TNF-α and TGF-β in the tibialis anterior muscle of rats following cryoinjury. Muscle regeneration involves cell proliferation, migration and differentiation and is regulated by growth factors and cytokines. A growing body of evidence suggests that LLLT promotes skeletal muscle regeneration by reducing the duration of acute inflammation and accelerating tissue repair. Adult male Wistar rats (n = 35) were randomly divided into three groups: control group (no lesion, untreated, n = 5), cryoinjury without LLLT group (n = 15), and cryoinjury with LLLT group (n = 15). The injured region was irradiated three times a week using an AlGaInP laser (660 nm; beam spot 0.04 cm2, output power 20 mW, power density 500 mW/cm2, energy density 5 J/cm2, exposure time 10 s). Muscle remodeling was evaluated at 1, 7 and 14 days (long-term) following injury. The muscles were removed and total RNA was isolated using TRIzol reagent and cDNA synthesis. Real-time polymerase chain reactions were performed using TNF-α and TGF-β primers; GAPDH was used to normalize the data. LLLT caused a decrease in TNF-α mRNA expression at 1 and 7 days following injury and in TGF-β mRNA expression at 7 days following cryoinjury in comparison to the control group. LLLT modulated cytokine expression during short-term muscle remodeling, inducing a decrease in TNF-α and TGF-β.  相似文献   
40.

Background  

Recent data indicate that enhanced wear resistance can be obtained with new cross-linked ultra-high-molecular weight polyethylene (CL-UHMWPE) liners, in comparison with previous-generation liners. The current prospective, cohort study was undertaken to analyse whether the use of a new CL-UHMWPE (Rexpol) results in a lower wear rate than ultra-high-molecular weight polyethylene (UHMWPE) in a group of similar patients undergoing total hip arthroplasty (THA). This study provides the first clinical data with this particular CL-UHMWPE.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号